Trial Profile
Sugammadex Versus Neostigmine for Antagonism of Rocuronium-induced Neuromuscular Blockade in Patients With Liver Cirrhosis Undergoing Liver Resection: A Controlled Randomized Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine; Rocuronium bromide
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 01 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Apr 2015 New trial record